Get the Stockscreener App
2.00
5.82%
0.11
Pre-market:
2.00
Io Biotech Inc stock is traded at $2.00, with a volume of 920.08K.
It is up +5.82% in the last 24 hours and up +51.52% over the past month.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$1.89
Open:
$1.91
24h Volume:
920.08K
Relative Volume:
4.81
Market Cap:
$131.76M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.927
EPS:
-2.1574
Net Cash Flow:
$-72.06M
1W Performance:
+42.86%
1M Performance:
+51.52%
6M Performance:
+139.06%
1Y Performance:
+51.52%
1-Day Range:
$1.76
$2.00
1-Week Range:
$1.34
$2.00
52-Week Range:
$0.66
$2.00
Io Biotech Inc Stock (IOBT) Company Profile
Name
Io Biotech Inc
Sector
Industry
Phone
(457) 070-2980
Address
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
2.00 | 92.23M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Io Biotech Inc Stock (IOBT) Latest News
IO Biotech, Inc.'s (NASDAQ:IOBT) largest shareholders are private equity firms who were rewarded as market cap surged US$16m last week - simplywall.st
Private equity firms are IO Biotech, Inc.'s (NASDAQ:IOBT) biggest owners and were rewarded after market cap rose by US$16m last week - Yahoo Finance
Why BrightSpire Capital Inc. stock attracts strong analyst attentionFree Investment Portfolio Suggestions - Newser
Why Chesapeake Utilities Corporation stock attracts strong analyst attentionSmart Money Signals - Newser
How IO Biotech Inc. stock performs during market volatilityTrade With Low Risk Exposure - Newser
What makes IO Biotech Inc. stock price move sharplySmart Trading With Safety Margin - Newser
How OXBR stock performs during market volatilityGrowth Optimized Stock Radar - Newser
Why Semtech Corporation stock attracts strong analyst attentionFree Trading Strategy Suggestions - Newser
Does IO Biotech Inc (NASDAQ: IOBT) Still Need To Convince Analysts? - Stocksregister
What makes La Rosa Holdings Corp. stock price move sharplyFree Stock Market Beginners Guide - Newser
How The Shyft Group Inc. stock performs during market volatilityReal Trader Insights - Newser
How Douglas Dynamics Inc. stock performs during market volatilityDefensive Stock Picks with Upside - Newser
Why Medalist Diversified REIT Inc. stock attracts strong analyst attentionReal Chart Play - Newser
How Zillow Group Inc. stock performs during market volatilityTriple Return With Stability - Newser
Company stock price move sharplyExpert Trading Flow - Newser
Why IO Biotech Inc. stock attracts strong analyst attentionBreakout Momentum Alerts - Newser
ProKidney's Innovative CKD Treatment Sparks Biotech InterestNews and Statistics - IndexBox
FDA Transparency: A Catalyst for Market Efficiency and Regulatory Risk Mitigation in Biotech/Pharma - AInvest
Top 5 Synthetic Biology Public Companies (July 2025) - Securities.io
IO Biotech (NASDAQ:IOBT) Shares Up 1.4% – Here’s What Happened - Defense World
Melanoma Pipeline Appears Robust With 150+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com
Top 5 Lab-Grown Meat Stocks to Invest In (July 2025) - Securities.io
IO Biotech secures €12.5M EIB funding, issues 4.2M-share warrant | IOBT SEC FilingForm 8-K - Stock Titan
IO Biotech Amends CEO Service Agreement - TipRanks
IO Biotech, Inc. (NASDAQ:IOBT) Short Interest Down 35.0% in May - Defense World
IO Biotech Regains Nasdaq Compliance with Stock Price - MSN
Wall Street Zen Upgrades IO Biotech (NASDAQ:IOBT) to “Sell” - Defense World
NSCLC Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 10+ Companies and 10+ Therapies | DelveInsight - The Globe and Mail
Metastatic Melanoma Pipeline Appears Robust With 20+ Key Pharma - openPR.com
IO Biotech reports annual meeting results By Investing.com - Investing.com Nigeria
IO Biotech reports annual meeting results - Investing.com India
IO Biotech Elects New Director at Annual Meeting - TipRanks
Citadel Advisors LLC Purchases Shares of 270,504 IO Biotech, Inc. (NASDAQ:IOBT) - Defense World
IO Biotech Regains Compliance With Nasdaq Listing Rules - marketscreener.com
io biotech regains nasdaq compliance after bid price recovery By Investing.com - Investing.com India
io biotech regains nasdaq compliance after bid price recovery - Investing.com
Director Heidi Hunter Acquires 15,000 Shares of IO Biotech Inc (IOBT) - GuruFocus
Stocks in play: Corus Entertainment - The Globe and Mail
Io biotech director Heidi Hunter purchases $20,884 in common stock By Investing.com - Investing.com South Africa
Io biotech director Heidi Hunter purchases $20,884 in common stock - Investing.com Australia
Top 10 Pharmaceutical Stocks For Healthcare Innovation (June 2025) - Securities.io
Here Are My Top 3 High-Yield Pipeline Stocks to Buy Now - The Globe and Mail
Pembina Pipeline Corporation Announces Redemption of Series 19 Preferred Shares - The Globe and Mail
3 Internet Software Stocks to Buy From a Prospering Industry - The Globe and Mail
Cancer Vaccines Market Sees Boost from UK's New Injection and Korea's Cell Conversion Research - openPR.com
Io Biotech Inc Stock (IOBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):